Podcasts about real chemistry

The question is no longer whether brands should work with influencers. It's about how brands can leverage culturally relevant influencers as part of an integrated digital ecosystem that drives brand impact while building trust, brand equity and advocacy, all while staying compliant within industry regulations. Healthcare brands face some of the toughest such regulations, which is why this sector is so helpful to examine in this regard. That is why the counsel offered on this podcast from Real Chemistry's Erin Bittner, president of integrated communications, and Bayer's Courtney Ambrosi, director of consumer integrated marketing strategy, women's healthcare, is so valuable. During this conversation, the two discuss why cultural relevance and authenticity matter more than reach. They provide a blueprint for integration in a digital ecosystem. Help in measuring both the hard and soft value of influencer marketing is provided. And they make a compelling case for why compliance is a catalyst, not a constraint, for stronger influencer partnerships. If you want to learn how to work with influencers in a manner that will drive deeper credibility, connection and business impact, you've found the right podcast. PRWeek.comTheme music provided by TRIPLE SCOOP MUSICJaymes - First One Follow us: @PRWeekUSReceive the latest industry news, insights, and special reports. Start Your Free 1-Month Trial Subscription To PRWeek Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In about five weeks, adland will take over a small resort city in the south of France for a weeklong industry bonanza. The 2026 Cannes Lions International Festival of Creativity is on the horizon, slated for the last full week of June and rest assured, the medical marketing community will be there in force.  Nearly one month ago, the juries for Health & Wellness Lions and the Pharma Lions were announced, featuring a few North American-based creatives, including Chris Charles, executive creative director of Real Chemistry subsidiary 21Grams. You might remember Chris and his team for their Gold Pharma Lions-winning work on behalf of Biogen for Friedreich's Back, a darkly humorous campaign focused on the often terminal, rare condition Friedreich's ataxia. For this week's episode, Chris joins executive editor Jack O'Brien for a conversation about the early stages of the sizable task undertaken by the Cannes pharma jury and what trends he's keeping an eye on as they analyze the nominated work.  He also reflects on the success of Frederich's Back and why Cannes is important to pharma marketers. For our Trends segment, we're talking about the frustrating, mixed public health messaging surrounding the hantavirus cruise ship outbreak. Check us out at: mmm-online.com Follow us: YouTube: @MMM-onlineTikTok: @MMMnewsInstagram: @MMMnewsonlineTwitter/X: @MMMnewsLinkedIn: MM+M To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.Music: “Deep Reflection” by DP and Triple Scoop Music. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Jill Carter is a highly respected matchmaker and relationship coach known for blending emotional intelligence with a results-driven, deeply personal approach to modern dating.With years of experience working exclusively with affluent professionals, entrepreneurs, and business leaders, Jill has built a reputation for delivering exceptional success rates by focusing on what most dating services overlook - the human element. Her work centers on listening deeply, uncovering patterns, and helping clients get radically honest about what they truly want in love.Jill's expertise has been featured on national television, including RHOV – Real Housewives of Vancouver, where she interviewed Mary Zilba and successfully matched her with renowned businessman, author, and former Dragon's Den investor Brett Wilson. Her elite scouting skills were also instrumental in Bachelor Canada (2014), where she helped identify top finalists for the season.Before founding ModernPursuit Matchmaking, Jill honed her craft with leading firms such as Hearts Canada, It's Just Lunch, and Matchmaker for Hire, giving her rare insider insight into what doesn't work in dating, and what truly creates chemistry and lasting connection.At ModernPursuit, Jill delivers a bold, bespoke, and highly personalized matchmaking experience, earning trust by building relationships first and designing strategies around each client's lifestyle, values, and vision for partnership.If you're fascinated by love, psychology, chemistry, and high-performance relationships, this conversation with Jill Carter is one you won't want to miss.Support the showFollow me on Facebook ⬇️https://www.facebook.com/manuj.aggarwal❤️  ID -  Manuj Aggarwal■ LinkedIn: https://www.linkedin.com/in/manujaggarwal/ ■ Facebook: https://www.facebook.com/realmanuj■ Instagram: ...

Doug Simon, CEO of D S Simon Media, and Campbell O'Connor, Group Director, Media & Engagement at Real Chemistry, explore how AI is transforming healthcare communications and media relations. They discuss how audiences are increasingly turning to platforms like YouTube, LLMs, and other digital sources for health information. Campbell also shares insights on HealthGEO, Real Chemistry's proprietary AI search intelligence platform, and how it is helping organizations understand, manage, and shape how their science and brands are represented by AI-driven search.D S Simon Media is a recognized innovator in broadcast public relations and the creator of the industry's first AI-Powered Broadcast Media Tour™. Over the last five years the firm has scheduled and produced more than 5,000 media segments annually, further establishing itself as a category leader. Clients include top brands in healthcare, technology, travel, financial services, food and beverage, consumer goods, entertainment, retail, non-profits, and associations. Celebrating its 40th Anniversary in 2026, the company has won more than 125 industry awards.

Send us Fan MailLyme disease affects hundreds of thousands of people every year—and yet we still struggle to diagnose it, treat it, and prevent it.David Walsey is a strategic biotech leader with more than two decades of experience helping public life sciences companies translate scientific innovation into market impact. As Executive Director of the Bay Area Lyme Foundation ( https://www.bayarealyme.org/ ), David leads national efforts to accelerate research, improve diagnostics, and expand access to effective treatments for Lyme disease and other tick-borne illnesses—an area of growing public health urgency.Prior to joining the Foundation, David served as Senior Vice President of Corporate Affairs at MEI Pharma, where he oversaw corporate strategy, investor relations, and communications during a critical period for the company. His career spans leadership roles across the biotech ecosystem, including Alder Biopharmaceuticals, Optimer Pharmaceuticals, Sarepta Therapeutics, Arena Pharmaceuticals, and Maxim Pharmaceuticals, as well as strategic communications roles at agencies such as Real Chemistry (formerly W2O Group), The Ruth Group, and Noonan Russo.David began his professional journey as a practicing attorney in New York City, bringing a legal and financial lens to his later work in biotech leadership. He holds an LL.M. in Taxation from New York University School of Law, a J.D. from Brooklyn Law School, and a B.A. from Franklin and Marshall College.#LymeDisease #LymeVaccine #Pfizer #Biotech #VaccineScience #PublicHealth #TickBorneDisease #MedicalInnovation #Biotechnology #Healthcare #InfectiousDisease #ClinicalTrials #VLA15 #Pharma #DrugDevelopment #SciencePodcast #Longevity #Diagnostics #VenturePhilanthropy #BayAreaLyme #FutureOfMedicine #BioInnovation #HealthcareInnovation #MedicalResearchSupport the show

Hawks broadcaster Mike Conti joins Andy and Randy to talk about the Hawks current win streak, and their chances of making a playoff run.

David Walsey joined Bay Area Lyme Foundation as Executive Director in 2025. He is a strategic biotech leader with 25 years of experience advancing corporate objectives through strategy, communications, financing, and investor initiatives for public companies. Most recently, David served as Senior Vice President, Corporate Affairs at MEI Pharma, leading programs spanning corporate strategy, investor relations, and corporate communications. He previously held senior roles at Alder Biopharmaceuticals, Optimer Pharmaceuticals, Sarepta Therapeutics (formerly AVI BioPharma), Arena Pharmaceuticals, and Maxim Pharmaceuticals, and worked at agencies including Real Chemistry (formerly W20 Group), The Ruth Group, and Noonan Russo. He began his career as an attorney in private practice in New York City and holds an LL.M. in Taxation from New York University School of Law, a J.D. from Brooklyn Law School, and a B.A. from Franklin and Marshall College.

If you've ever chased chaos and called it love… This conversation will change you. In this deeply raw and transformative episode, Kelly Siegel sits down with Esin Pinarli, holistic therapist and founder of Eternal Wellness Counseling, for one of the most honest conversations ever recorded on Harder Than Life. Esin doesn't just teach trauma healing; she's lived it. From addiction and anxiety to nervous system collapse, Esin shares how unresolved trauma wires us for chaos, why we confuse intensity for chemistry, and how self-medication shows up not just as substances, but as productivity, relationships, and over-functioning. This episode is a masterclass in nervous system regulation, trauma bonds, implicit memory, emotional addiction, and real healing. If you've ever felt addicted to the wrong people, overwhelmed by your emotions, or stuck in patterns you “can't explain,” this conversation will give language to your experience and a path forward. Key Takeaways

Steve and Charlie praised the growing connection between Saints rookie quarterback Tyler Shough and second-year wide receiver Devaughn Vele. The guys listened to Saints RB Audric Estime's press conference audio. Former Saints Super Bowl-winning LB Scott Shanle, the team's analyst, joined Sports Talk. Shanle praised the growth and "it-factor" from rookie quarterback Tyler Shough. Shanle shared his thoughts on Kellen Moore, Cam Jordan, Devaughn Vele, and the Saints' test against the Jets.

The Women in AI Healthcare event series - hosted by Real Chemistry in collaboration with Pharma Brands – brings together dynamic female leaders to discuss the transformative role of artificial intelligence in life sciences. It is also a call to action: to ensure women are not only present, but pivotal in shaping the future of AI in healthcare. In a new pharmaphorum podcast focused on the important and timely subject of women in AI, web editor Nicole Raleigh spoke with: Kate Eversole, event director at Pharma Brands; Celine Parmentier, EVP, head of global med comms at Real Chemistry; and Emma Slade, head of applied AI at Tangram Therapeutics. The guests discuss their own work with AI, the risk of training AI models predominantly on male data, and how, within life sciences, women are already shaping, challenging, and advocating for AI. The conversation also touches upon the possible next greatest impacts of AI in the sector, and the need to keep the ‘human in the loop', as well as the possible negative impacts if AI is relied upon too much. You can listen to episode 232 of the pharmaphorum podcast in the player below, download the episode to your computer, or find it - and subscribe to the rest of the series – on Apple Podcasts, Spotify, Overcast, Pocket Casts, Podbean, and pretty much wherever else you download your other podcasts from.   Resources mentioned within the conversation are as below: Kotek, H., Dockum, R., & Sun, C. (2023). Gender Bias and Stereotypes in Large Language Models. arXiv:2304.02485. UN Women & UNESCO (2020). I'd Blush If I Could: Closing Gender Divides in Digital Skills Through Education. Tatman, R. (2017). Gender and dialect bias in YouTube's automatic captions. Criado-Perez, C. (2019). Invisible Women: Data Bias in a World Designed for Men. King, M. (2020). The Fix: Overcome the Invisible Barriers That Are Holding Women Back at Work.   You can register to be a part of the women in AI community here: https://www.pharmabrands.ca/womeninai   Information on the survey being run by Dr Michelle Penelope King, on AI and workplace motivation, can be found here: https://lnkd.in/eCg87_7w

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a series of pivotal changes and innovations shaping the industry landscape.Let's begin with a significant acquisition that is resonating across the sector. Alkermes has strategically acquired Avadel Pharmaceuticals for a noteworthy $2.1 billion. This acquisition is primarily aimed at Avadel's long-acting narcolepsy drug, Lumryz. This move not only acts as a growth catalyst for Alkermes but also strategically positions the company to potentially advance its own narcolepsy candidate, Alixorexton. This acquisition highlights a broader trend within the industry: a shift towards consolidation and specialization in niche therapeutic areas, reflecting the ongoing strategic maneuvering within the pharmaceutical sector to enhance therapeutic portfolios.In regulatory developments, there is an ongoing discussion around FDA cancer drug policies that's gaining attention. Eli Lilly's Oncology President has highlighted the need for clearer regulatory pathways. The debate revolves around whether to prioritize survival metrics without crossover incentives or encourage U.S. participation through crossover designs. This underscores a tension between maintaining regulatory rigor and offering flexibility in clinical trial design—a balance that impacts how quickly new oncology therapies can reach patients.Turning to international trade, there are significant movements as the Trump administration initiates a probe under Section 301 of the Trade Act of 1974. The aim is to assess if foreign nations are contributing their fair share to drug costs. Such an investigation could lead to tariffs, potentially altering global pharmaceutical trade dynamics and influencing international pricing strategies. Reports suggest that former President Donald Trump is exploring strategies to impose tariffs on U.S. trading partners not adequately compensating for pharmaceuticals, reflecting ongoing tensions regarding international drug pricing.Technology is revolutionizing life sciences commercialization strategies, with AI playing a pivotal role. Despite many organizations not being fully prepared for this digital shift, companies like Real Chemistry are pioneering AI applications to navigate regulatory complexities such as FDA marketing compliance. This digital transformation is set to redefine how pharmaceutical companies engage with patients and healthcare providers, enhancing efficiency and compliance.In legal news, Regeneron has settled a patent dispute with Celltrion over Eylea, allowing for the launch of a biosimilar by the end of 2026. This settlement is part of the growing biosimilars market, which offers cost-effective alternatives to high-priced biologics and enhances patient access to essential therapies.The industry's focus on oncology is further exemplified by Takeda's $1.2 billion upfront payment to Innovent Biologics for cancer assets. This deal includes substantial milestone payments, marking oncology as a key growth area post-Entyvio era and highlighting the high stakes associated with breakthrough cancer therapies. Continuing with significant industry maneuvers, Takeda Pharmaceuticals has announced a potential investment up to $11.4 billion to acquire three antibody-drug conjugates from Innovent Biologics. This deal includes an upfront payment of $1.2 billion and up to $10.2 billion in milestone payments—highlighting Takeda's commitment to expanding its oncology portfolio with innovative therapies that promise enhanced treatment outcomes for cancer patients.Ipsen's acquisition of ImCheck Therapeutics for $1.6 billion further emphasizes this focus on novel cancer treatments. The move includes ImCheck's mid-stage leukemia monoclonal antibody ICT01—an asset aimed at acute myeloid leukemia—indicating Ipsen's strategic push intSupport the show

Are the Patriots back? Tom E. Curran and Phil Perry react to the buzz around the Patriots after their statement win over the Bills. They discuss Drake Maye's strong outing and take a closer look at the chemistry building between Maye and Stefon Diggs.1:00 - The Patriots are back in postseason conversation 8:00 - Breaking down Drake Maye's game management 18:00 - The chemistry between Diggs and Maye is blossoming WATCH every episode of the Patriots Talk podcast on YouTubeFollow NBC Sports Boston:NBCSportsBoston.comX @NBCSpatriotsFacebookInstagramTikTok Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Leave Health Bite a Feedback.Click This Link.If you think hunger is just about food, this story will change your mind. Jim Weiss, founder of Real Chemistry, shares how his drive for success masked a deeper hunger that no amount of achievement could satisfy.Why Listen to This Episode:Learn the difference between productive drive and destructive patternsDiscover practical mind-body tools that actually work for busy executivesSee how addressing physical hunger unlocks deeper emotional workUnderstand how loss can transform leadershipMeet Jim Weiss: Jim is founder of Real Chemistry, a leading medical marketing agency. After losing his wife Audra to cancer and facing his own health struggles, Jim discovered that sustainable success requires addressing both physical and emotional hunger through practical resilience practices.What You'll Learn:Why high achievers often seek validation through food, work, and substancesHow mind-body practices become accessible after physical hunger is managedThe connection between personal resilience and professional productivityWhy "putting the phone down" is crucial for preventing modern burnoutOn the Deeper Hunger: "There's a deeper hunger that doesn't get addressed more directly. Is it hunger for acceptance or love or recognition? So where do you look for it? 'Wow, this tequila tastes really good.'" - Jim WeissReady to Address Your Deeper Hunger? Resilient Minds offers 8 weeks of practical mind-body tools for high-achieving professionals ready to move beyond burnout into sustainable leadership.Starting September 30th. Limited spots available.Learn more: https://www.doctoradrienneyoudim.com/resilient-minds3 Ways that Dr. Adrienne Youdim Can Support You Join Resilient Minds: If this sounds familiar, you're exactly who Resilient Minds is designed for. Next cohort starts September 30th - Limited to 12 high-achieving professionals ready to move from success to significance.Ready to stop asking "Is this it?" and start living like you know it isn't?Application details here: https://www.dradrienneyoudim.com/resilient-minds Subscribe to Dr. Adrienne's weekly newsletter https://www.dradrienneyoudim.com/newsletter. Connect on Instagram : Follow @dradrienneyoudim for tips and inspiration on well-being and peak performance.

Welcome to our review of PR pitches and mergers & acquisitions in the UK PR scene with Andrew Bloch. Here we discuss the biggest pitch wins and mergers & acquisitions that the PR sector has seen in July 2025Andrew is the lead consultant - PR, Social, Content and Influencer at the new business consultancy firm AAR and a partner at PCB Partners, where he advises on buying and selling marketing services agencies.The Creative Moment Awards have sold out but we have an fascinating webinar on GEO, Misinformation and the News: The Impact of AI on Trust of the Media and a PR Planning event on October 16th.Also, thanks so much to the PRmoment Podcast sponsors the PRCA.PITCHESCop30 appoints Edelman – Comms activity around Brazil's hosting of Summit in Nov. Account worth $834,850 from mid-July – mid Feb 26 (according to US Foreign Agent Registration Act).Tokyo appoints Weber Shandwick – $1.7m year long deal with Tokyo Metro Govt. Morocco National Tourist Office appoints Rooster – UK and Ireland brief to promote tourism in Morocco.Ethara Event and Entertainment appoints The Romans – Etihad Airways GP. 2 year b2b and b2c brief.W Hotels appoint The Romans – EMEA PR strategy for global hotel brands across the UK and Middle East.Lidl appoints Brands2Life - corporate and public affairs brief - building and painting reputation in a way that is ‘commensurate with its economic and social impact across the nation'. Media relations, give relations, leadership comms, crisis mitigation. Category defining business. 5th biggest supermarket in UK by food and drink sales. Brands2Life also looks after LinkedIn, TetraPak. Vodafone, XeroHomesense appoints Pretty Green - consumer pr, influencer and social brief.Wasabi Sushi & Bento appoints The Fitting Room - a PR, social and content.consumer comms brief across 41 stores.Itsu grocery appoints Exposure – creative comms for new rice noodle range! Innocent adds Tin Man and Pretty Green –to its roster of agencies.LEGO appoints Smarts – UK and Ireland consumer PR brief. Lego's first new agency in 8 years. Recent wins Asda and People's Postcode Lottery.Specsavers appoints Firstlight Group as its UK retained communications agency. Have worked on projects since 2021. Firstlight will work alongside Golin and Tangerine. Street Soccer London appoints The Ripple Effect.Police Care UK –appoints PHA Group –a charity for serving and veteran police officers and staff, volunteers, and their families, who have suffered any physical or psychological harm as a result of policing.Shieldpay appoints PHA GroupVinted appoints John DoeJigsaw appoints Aisle8Mint Velvet appoint EmergeHexclad cookware appoints Milk and Honey Stagecoach appoints McCann BirminghamSodastream appoints Visible This month's round up of M&A activityReal Chemistry acquire Greater Than OneGTO will gain access to Real Chemistry's services in AI driven, creative, influencer engagement, medical comms, integrated comms and market access. Real Chemistry is $665M globally of which circa $616M is in the US pushing it above Edelman as the largest US firm by revenue last year.WE Communications (formerly Wagner Edstrom) and Hopscotch merged. WE acquired Hopscotch 3 years ago.MSQ acquires Precious Media and Wooshi to expand production capabilities. Doubles M3 Labs (MSQ's production agency) headcount to 130 adding AI powered and commerce focussed production expertis

Video games are big fun and even bigger money.The International Trade Administration estimated that the value of the global video game industry in 2023 was $184 billion – with more than 3.2 billion gamers worldwide. Recognizing this new trend in media consumption and content engagement, medical marketers have been trying to break through in the gaming world.Few have had as much success as Level Ex – which develops video games for physicians.Almost a year ago, Level Ex was bought by Relevate Health, a 2025 MM+M Agency 100 honoree. Recently, the Level Ex brand was dissolved and the studio now operates under the Relevate Health branding.Level Ex's founder Sam Glassenberg is the father of a child living with type 1 diabetes. He recently worked with his team to launch a free game for newly diagnosed patients and their caregivers to onboard them to diabetes care management management.For this week's episode, Pharma Editor Lecia Bushak spoke with Glassenberg about the diabetes video game's launch over the summer, an update on the first year under Relevate Health and what opportunities video games present to medical marketers.And for our Trends segment, we're talking about some recent AI projects launched by Real Chemistry and Eversana Intouch.Music: “Deep Reflection” by DP and Triple Scoop Music. Step into the future of health media at the MM+M Media Summit on October 30th, 2025 live in NYC! Join top voices in pharma marketing for a full day of forward-thinking discussions on AI, streaming, retail media, and more. Explore the latest in omnichannel strategy, personalization, media trust, and data privacy—all under one roof. Don't wait—use promo code PODCAST for $100 off your individual ticket. Click here to register! AI Deciphered is back—live in New York City this November 13th.Join leaders from brands, agencies, and platforms for a future-focused conversation on how AI is transforming media, marketing, and the retail experience. Ready to future-proof your strategy? Secure your spot now at aidecipheredsummit.com. Use code POD at check out for $100 your ticket! Check us out at: mmm-online.com Follow us: YouTube: @MMM-onlineTikTok: @MMMnewsInstagram: @MMMnewsonlineTwitter/X: @MMMnewsLinkedIn: MM+M To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.Music: “Deep Reflection” by DP and Triple Scoop Music.

On this edition of The PR Week, we're thrilled to welcome JJ Carter, who took the helm as CEO of FleishmanHillard last October.Join us as he discusses the agency's evolution, particularly in light of Omnicom Group's pending acquisition of rival Interpublic Group. Plus, we'll dive into the week's biggest marketing and communications news, including IPG's Q2 earnings, Real Chemistry's latest acquisition and Astronomer's viral crisis.Plus: The 2025 PRWeek US Power List, which features the CEO of Omnicom PR Group in the top slot.  AI Deciphered is back—live in New York City this November 13th.Join leaders from brands, agencies, and platforms for a future-focused conversation on how AI is transforming media, marketing, and the retail experience. Ready to future-proof your strategy? Secure your spot now at aidecipheredsummit.com. Use code POD at check out for $100 your ticket! Follow us: @PRWeekUSReceive the latest industry news, insights, and special reports. Start Your Free 1-Month Trial Subscription To PRWeek

There's a lot of mixed information out there when it comes to health especially online. One day you'll hear high-protein diets are bad for your kidneys, the next someone says you can reverse type 2 diabetes without changing your diet or exercising. It's no wonder people feel overwhelmed and unsure of what to believe.It offers a more grounded perspective focusing on how our bodies were designed to function and what real, unprocessed food can do for our health. It also touches on how effort and consistency still matter and why it's okay to question health trends that promise quick and easy fixes.Highlights of the Podcast01:27 - Questioning Bold Claims03:00 - Real Chemistry vs. Health Trends04:48 - Processed vs. Whole Foods06:18 - Reversing Type 2 Diabetes Naturally08:01 - Putting in the Work for Real Health09:17 - Adjusting to Real Food Again11:04 - Use Nature as Your Filter12:37 - Supplements and Biochemical Relevance14:02 - COVID, Iodine, and Hair Loss15:41 - Influencer Incentives & Media Censorship16:30 - Trust, Transparency, and Censorship in Health

Pam Jenkins recently left Weber Shandwick, where she spent the last two decades, to join nonprofit Shatterproof as its CEO. The organization works to reduce the burden of substance use disorder in the U.S. by increasing access to treatment, expanding education and driving public policy change. Jenkins talks about her previous work with Shatterproof at Weber and her plans for the nonprofit.Plus, the biggest marketing and communications news of the week, such as Omnicom's poor PR financial results in Q2; reports of a possible tie-up between WPP and Accenture; and prominent people moves at Real Chemistry and Golin.  AI Deciphered is back—live in New York City this November 13th.Join leaders from brands, agencies, and platforms for a future-focused conversation on how AI is transforming media, marketing, and the retail experience. Ready to future-proof your strategy? Secure your spot now at aidecipheredsummit.com. Use code POD at check out for $100 your ticket! Follow us: @PRWeekUSReceive the latest industry news, insights, and special reports. Start Your Free 1-Month Trial Subscription To PRWeek

Join Frank Mazzola, chief creative officer, Real Chemistry; and Alok Gadkar, cofounder, CEO and CCO, Tuesday Communications, to hear stories from behind the jury room door. As members of this year's Pharma Lions Jury, Mazzola and Gadkar share what it's like in the room, trends from this year's awards and how pharma clients can get engaged. AI Deciphered is back—live in New York City this November 13th.Join leaders from brands, agencies, and platforms for a future-focused conversation on how AI is transforming media, marketing, and the retail experience. Ready to future-proof your strategy? Secure your spot now at aidecipheredsummit.com. Use code POD at check out for $100 your ticket! campaignlive.com What we know about advertising, you should know about advertising. Start your 1-month FREE trial to Campaign US.

Join Frank Mazzola, chief creative officer, Real Chemistry; and Alok Gadkar, cofounder, CEO and CCO, Tuesday Communications, to hear stories from behind the jury room door. As members of this year's Pharma Lions Jury, Mazzola and Gadkar share what it's like in the room, trends from this year's awards and how pharma clients can get engaged. Step into the future of health media at the MM+M Media Summit on October 30th, 2025 live in NYC! Join top voices in pharma marketing for a full day of forward-thinking discussions on AI, streaming, retail media, and more. Explore the latest in omnichannel strategy, personalization, media trust, and data privacy—all under one roof. Don't wait—use promo code PODCAST for $100 off your individual ticket. Click here to register! AI Deciphered is back—live in New York City this November 13th.Join leaders from brands, agencies, and platforms for a future-focused conversation on how AI is transforming media, marketing, and the retail experience. Ready to future-proof your strategy? Secure your spot now at aidecipheredsummit.com. Use code POD at check out for $100 your ticket! Check us out at: mmm-online.com Follow us: YouTube: @MMM-onlineTikTok: @MMMnewsInstagram: @MMMnewsonlineTwitter/X: @MMMnewsLinkedIn: MM+M To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.

In the 100th episode of the PR Masters Podcast, host Art Stevens marks this milestone with a deeply personal and inspiring conversation with one of the communications industry's most transformative figures: Jim Weiss, Chairman and Founder of Real Chemistry.

What does it take to secure, plan and execute a main stage presentation at Cannes? Christopher Charles, executive creative director at 21Grams, and Fiona Cauley, a comedian with Friedreich's Ataxia, who recently opened for Nikki Glaser, are fresh from their presentation on the main stage at Cannes. Hear the behind-the-scenes story of their presentation, how it went and what they believe the impact will be for healthcare marketing.  AI Deciphered is back—live in New York City this November 13th.Join leaders from brands, agencies, and platforms for a future-focused conversation on how AI is transforming media, marketing, and the retail experience. Ready to future-proof your strategy? Secure your spot now at aidecipheredsummit.com. Use code POD at check out for $100 your ticket! campaignlive.com What we know about advertising, you should know about advertising. Start your 1-month FREE trial to Campaign US.

What does it take to secure, plan and execute a main stage presentation at Cannes? Christopher Charles, executive creative director at 21Grams, and Fiona Cauley, a comedian with Friedreich's Ataxia, who recently opened for Nikki Glaser, are fresh from their presentation on the main stage at Cannes. Hear the behind-the-scenes story of their presentation, how it went and what they believe the impact will be for healthcare marketing.Step into the future of health media at the MM+M Media Summit on October 30th, 2025 live in NYC! Join top voices in pharma marketing for a full day of forward-thinking discussions on AI, streaming, retail media, and more. Explore the latest in omnichannel strategy, personalization, media trust, and data privacy—all under one roof. Don't wait—use promo code PODCAST for $100 off your individual ticket. Click here to register!    AI Deciphered is back—live in New York City this November 13th.Join leaders from brands, agencies, and platforms for a future-focused conversation on how AI is transforming media, marketing, and the retail experience. Ready to future-proof your strategy? Secure your spot now at aidecipheredsummit.com. Use code POD at check out for $100 your ticket!    Check us out at: mmm-online.com   Follow us:  YouTube: @MMM-online TikTok: @MMMnews Instagram: @MMMnewsonline Twitter/X: @MMMnews LinkedIn: MM+M   To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.

Maybe the biggest news to come out of PRWeek's Agency Business Report 2025 was that Real Chemistry supplanted Edelman as the No. 1 PR firm in the U.S. by revenue for 2024. Real Chemistry CEO Shankar Narayanan talks about that honor, and what the disposal of specialist shop Swoop will mean for his firm, on the latest edition of The PR Week podcast. He also previews Real Chemistry's presence at the Cannes Lions International Festival of Creativity, talks about how nearly all of his firm's work is rooted in communications and discusses what happens when large organizations combine — spoiler: they don't become more creative. Plus, the biggest marketing and communications news of the week, from the opening honorees on PRWeek's Pride in PR list to McDonald's chief impact officer Michael Gonda's new job at Nike.   Follow us: @PRWeekUSReceive the latest industry news, insights, and special reports. Start Your Free 1-Month Trial Subscription To PRWeek

“Writing steamy scenes is easy—it's getting my characters to talk afterward that's the hard part.” In this episode of the Fresh Fiction Podcast, Samantha Tennant sits down with fan-favorite romance author Jade Lee—also known as Kathy Lyons—to talk all things love, laughter, and literary scandal! We're diving into THE DUKE'S GUIDE TO FAKE COURTSHIP, a Regency romance that's full of witty banter, unexpected twists, and a deliciously slow-burn love story you won't want to miss. Jade shares how she brings humor and heart to historical fiction, her favorite tropes to write, and the secret behind creating irresistible chemistry between characters. Whether you're a longtime fan or just discovering her books, this episode is packed with insights, laughs, and bookish joy.  Tune in, subscribe, and don't forget to tell your fellow romance readers!  Find more great reads at FreshFiction.com

Introducing Live from SXSW - The Future of Scientific Communications Through Podcasting from Science Will Win.Follow the show: Science Will WinPodcasting has become essential for communicating breakthroughs in science, offering an accessible and engaging platform to reach diverse audiences. This evolving medium fosters deeper connections by delivering trusted information in accessible and compelling ways. In this conversation, audio makers from Pfizer, Acast, and TED, discuss what it takes to stand out in the science podcast space, insights on strategy, and how they're working to shape the future of health communication.Moderator• Aaron Strout, Former CMO of Real Chemistry and Health PodcasterSpeakers• Erica Santiago, Executive/Digital Communications & Podcast Strategy, Pfizer• Veronika Taylor, SVP of Acast's Creator Network• Shoshana Ungerleider MD, Host and Producer of TED Health PodcastThis episode was recorded live in Austin, TX on Monday, March 10, as part of Pfizer's takeover of the South by Southwest podcasting lounge.Please fill out our short survey so we can get to know our listeners better: pfizer.com/podcastsurvey DISCLAIMER: Please note, this is an independent podcast episode not affiliated with, endorsed by, or produced in conjunction with the host podcast feed or any of its media entities. The views and opinions expressed in this episode are solely those of the creators and guests. For any concerns, please reach out to team@podroll.fm.

Welcome to S3E05 of IMpulse, the Influencer Marketing Podcast! In this episode, we're joined by Aaron Strout, former Chief Marketing Officer at Real Chemistry, a global health innovation company that's transforming how healthcare brands tell stories using data, digital innovation, and AI. Aaron dives deep into the impact of AI on marketing, from influencer vetting and brand safety to content personalization and campaign optimization. He talks about why human oversight still matters in an AI-first world, how to spot hallucinations in generative tools, and what “agentic search” means for influencer discovery. Plus, he shares his bold 2030 prediction for AI's role in marketing and how brands can stay authentic without losing creative momentum.

Gary Welch is a medical illustrator and animator based in Philadelphia. A graduate of the RIT program, Gary has worked at 3FX, MadMicrobe, and is now Production Supervisor at Real Chemistry. Show notes: https://www.pkvisualization.com/post/mip-gary-welch-interview

Ben Chapman is the General Counsel and Chief Privacy Officer at Swoop. Prior to Swoop, Ben was the Deputy General Counsel for Real Chemistry. He has nearly 10 years of experience in ad tech, data, and privacy matters. In this episode… Companies that operate in the healthcare marketing space, like Swoop, approach privacy by emphasizing transparency, ethical practices, and building trusted partnerships. To remain compliant, businesses need to thoroughly understand their data handling processes and regularly assess their partners. By asking detailed, factual questions, companies can make informed decisions about their partners' practices and ultimately strengthen their privacy programs. Additionally, adopting a consumer- or patient-centric perspective helps businesses navigate the complexities of privacy laws while aligning with regulatory requirements and ethical standards. A proactive and well-informed approach to privacy strengthens compliance efforts and builds trust. Healthcare marketing faces new challenges as privacy laws evolve and health data definitions expand. Laws like the Washington My Health My Data Act broaden the scope of what constitutes health data, requiring organizations to reevaluate how they handle consumer data. Navigating this complex regulatory landscape requires companies to ensure compliance with state privacy laws and federal regulations like HIPAA, all while maintaining trust and transparency with consumers. How can companies ensure ethical and privacy-friendly marketing practices? In this episode of She Said Privacy/He Said Security, Jodi and Justin Daniels speak with Ben Chapman, General Counsel and Chief Privacy Officer at Swoop, about the intersection of privacy and healthcare marketing. They discuss how state privacy laws redefine health data, the importance of ethical data practices, and strategies for evaluating partners. Ben shares his insights on building privacy programs, fostering collaboration, and navigating the nuances of healthcare marketing in a highly regulated environment. He also highlights the importance of continuous learning and collaboration within the privacy community to stay ahead in the ever-changing regulatory environment.

In this episode of Harmony Talk, Todd Stephens interviews Jim Weiss, Founder and Chairman of Real Chemistry, a global marketing and communications firm focused on the healthcare industry. Jim discusses the vital role of communication in healthcare, his journey from corporate life to entrepreneurship, and the importance of mentorship and giving back to the community. He shares insights on leadership, the influence of his small-town upbringing, and his aspirations for the future. Key Takeaways: Real Chemistry helps organizations tell their story effectively. Communication is a key component of leadership. Jim Weiss transitioned from corporate roles to entrepreneurship. Mentorship played a significant role in Jim's career. Growing up in a small town shaped Jim's values and work ethic. FOLLOW HARMONYTALK PODCAST @harmonytalkpodcast Join Our Mailing List: https://www.harmonytalkpodcast.com/signup Instagram: https://instagram.com/harmonytalkpodcast Facebook: https://www.facebook.com/harmonytalkpodcast YouTube: https://youtube.com/@HarmonyTALKPodcast LinkedIn: https://www.linkedin.com/company/harmonytalkpodcast https://harmonytalkpodcast.com/ Follow Host, Todd Stephens: https://www.instagram.com/workinman1/ Email harmonytalkpodcast@gmail.com for sponsorship and guest opportunities! See omnystudio.com/listener for privacy information.

Send us a textIn this episode of Transcending Home Care, Tony Kudner talks with April Dovorany, earned media expert at Real Chemistry, about sharing impactful patient stories. Learn how to craft pitches, engage local media, and navigate patient privacy to highlight the extraordinary care provided by home-based organizations while boosting visibility and community impact.

Welcome to our review of PR Pitches and mergers & acquisitions in the UK PR scene with Andrew Bloch. Here we discuss the biggest pitch wins and mergers & acquisitions that the PR sector has seen in 2024.If you haven't heard already I'm pleased to say we've now launched our PR Masterclass: The Intersection of Data, Planning and Measurement event. Attend this PR Masterclass to hear from experts on the latest techniques, tools and case studies about the use of data in modern communications.The other big news in public relations is that the PRmoment Awards 2025 are open. The final entry deadline is on January 17th. Miss it and miss out!Also, thanks so much to the PRmoment Podcast sponsors the PRCA.JANUARYPitchesIceland appointed TangerineHenkel appointed BCW/BursonMinistry of Justice appointed KindredAirbnb  appointed The Romans.M&AMerger of BCW and H+K to become Burson and create a £1bn + agency.Bully Pullpit Interactive acquired Boldt. FEBRUARYPitches“This is often the hangover from the Golden Quarter Pitches that start to get announced.”Bolt appointed Boldspace.Burger King appointed The Academy.British Gas appointed Smarts. M&A SEC Newgate acquired a 70% stake (over 5 years) in Athens HQ V+O Group.Real Chemistry acquired Avant Healthcare -Havas acquired Ledger Bennett. MARCHPitchesPepsi appointed Hope & Glory.“The first change for Pepsi in 14 years. This was a big big brief.”Taco Bell appointed Earnies.“You never forget your first win'Pizza Express appointed Pretty Green. M&AMHP acquired La Plage (creative content above the line agency). First acquisition for MHP since its acquisition by Next15.W acquired Franses,Havas appointed WildernessAPRIL PitchesWilliam + Grant appointed Exposure.Shark Ninja appointed  BursonTinder appointed The AcademyCarlsberg appointed Hope&GloryEA appointed Premier.M&AAccenture bought Unlimited“In my mind one of the smartest deals that was done this year.”WPP announced that leading global investment firm KKR has made a growth investment in FGS Global.“WPP has focused on releasing cash and consolidation and they've done that impeccably well.”“The holding companies and the big private equity firms have all realised that scale is important.”MAYPitchesEDF appointed Tin Man/Lucky Generals“What we've seen in consumer PR is... the agencies who went into the year strongest, have come out even stronger.”Reebok appointed Brand Nation.Pringles appointed Mischief MHP.Unilever appointed Golin“Nothing beats the UK, no one comes close, in terms of strategic creativity.”M&APagefield sells to PPHC.JUNE/JULYPITCHESFamous Grouse appointed Pretty Green.B&Q appointed Romans.Homebase appointed Aduro.The Independent appointed W.WRAP appointed Kindred.National Grid appointed 9 agencies to a “Community Agency Framework” for next 3 years – Grayling, Cavendish, Lexington, Aecom, Arup, Camargue, Copper, grasshopper, JBP.M&APublicis acquired Influential.Havas - acquired a controlling stake in Klareco Communications.Prime Weber Shandwick – MBO. AUGPITCHESMoet Hennessy appointed Earnies - wines and spirits division of LVMH.Dept for Education appointed FourArla Foods -appointed City Press.  

This show is going to be a little bit different because what we're going to do today is offer some advice to those who may work at a pharma company. But before we get into this advice portion of the discussion, let's start here. For a full transcript of this episode, click here. If you enjoy this podcast, be sure to subscribe to the free weekly newsletter to be a member of the Relentless Tribe. Probably we're gonna have people listening to this episode who maybe are not in our normal tribe of Relentless Health Value listeners. While there are, for sure, regular listeners who work at pharma companies, there might be some newbies on the scene here. And to you, I say welcome. I hope that you feel right at home here. You know what, though? Many of us, including myself often enough, are slightly uncomfortable. Because this is the place where we all kind of look at ourselves in the mirror. We all live in glass houses, after all—everyone in the healthcare industry. There's no devils and no angels here. And the trick is maximizing the good and minimizing the not so good so that we all wind up with the highest net positive possible for patients. So, around here, we do not shy away from saying what needs to be said so that we all can find a way forward to serve the patient. We cannot solve problems, after all, that we have not taken a cold, hard look at. Yeah. So, today I am speaking with Brian Reid. I have been very much looking forward to speaking with Brian Reid, who many may know from his really great newsletter and really insightful LinkedIn posts. Brian Reid's advice, which he delivers in the episode that follows in sum. Spoiler alert here, but I also will say that he is much more eloquent than me, and the nuances are a thing. So, please do listen to the whole show. But Brian's piece of advice number one for Pharma (and really any product or service frankly), but piece of advice number one is this: Get a really solid bead on what value means—not just to PBMs (pharmacy benefit managers) or contract pharmacies or wholesalers who are middlemen but to the ultimate purchasers, the ones whose wallets the money is actually coming out of to pay the bill. Meaning, plan sponsors, such as self-insured employers or unions, patients themselves or members, and taxpayers. Again, how does value accrue to the ultimate purchasers like plan sponsors, patients/members, or taxpayers? Everybody else in the drug supply chain, let's be clear, is in the middle pushing money around that came out of somebody else's wallet. These middlemen have their own interests that may, for sure, may or may not be aligned with the interests of the ultimate purchasers. Getting value realized by patients will depend on understanding what the value is to these ultimate purchasers and then not getting derailed by any middleman who may not be so aligned. As a sidebar on this number one piece of advice, the whole “what's your value” and influence coloring this value equation made by ultimate purchasers is the prevailing beliefs of these ultimate purchasers, relative to Pharma, how they perceive the pharma industry. Whether it's earned or not—and this is not what we're gonna discuss today—but earned or not, Pharma does not have a great reputation with these folks right now. And this matters. Brian has a lot to say on this topic, which is fascinating. So, you should listen. Number two piece of advice that Brian Reid delivers in the podcast that follows that we talk about: Consider inching into the fray around benefit design. Rightfully so, there's always a lot of talk about patient affordability at pharma companies; but if I was gonna point to one thing that impacts affordability more than anything else, it'd be benefit design. There's only a small, underfunded cadre right now of folks out there (Mark Cuban aside, actually); but there's only a really small number of folks who never have any money who are really helping plan sponsors understand the impact on patients of some of the choices that they are making. I mean, personally, I could think of 10 things to do right off the top of my head that could help plan sponsors not get inadvertently screwed in this realm alone, just thinking they're saving money when, in reality, they are harming patients and not saving money. There's probably a lot of opportunities to communicate these kinds of things that are really win-win collaborations. Number three piece of advice that we talk about in the conversation that follows with Brian Reid: Keep an eye on hospital consolidation and vertical integration in the payer space. Consolidation raises prices and impedes patient affordability. This is as per study after study after study. Consolidation raises prices and sometimes considerably. Here's a part B to this third piece of advice about consolidation. There's sometimes wild swings in prices at different large, consolidated health systems in the exact same geography. Listen to the show with Cora Opsahl (EP452) for more about how their health plan, as just one example, saved $30 million a year just pushing a huge expensive health system, consolidated one, out of their network and navigating patients to more affordable sites of care. This matters to pharma companies because hospital system prices are currently crushing in many areas of the country, really impacting patient affordability. But there are better or worse options from an affordability standpoint in some of these geographies. To state the obvious, if an infusion of the same drug costs 10 times more if a patient shows up in one care setting versus another, that latter place, not affordable for patients. And by the way, that is not hyperbole of any kind. There are plenty of examples where literally an infusion of the same drug, same dosage will cost 10 times more if a patient goes one place versus another. But, again, it's not affordable. The patient cost share might be 10 times higher if it's coinsurance, if the patient goes to that latter place. And that latter 10x more of the cost place also just added 10x the cost to the PAP program or the foundation debit column. All of this is really relevant to Pharma. And just to pile on here because now I'm on a roll, another reason why this matters, these striking price variations between care settings, if we're talking about product value, and if the price the patient or the plan sponsor is paying is 10x the cost of the ingredients, nobody's doing that math and separating out the cost of ingredients from the, you know, total cost of the infusion. It is one lump sum number. So, if we're defining value as outcomes divided by cost and now the cost to the plan sponsor is 10x, product value just got reduced by 10x. Just in case anyone is confused here, and you probably know this, but many forget that the whole ASP (average selling price) plus 6% provider reimbursement—so, if that's what you're thinking and you're wondering how the 10x transpires—that ASP plus 6% provider reimbursement is only for Medicare kinds of plans. Hospitals can and do negotiate much higher reimbursements for commercial plans, and those carriers that have commercial lines of business and also MA (Medicare Advantage) books of business even allegedly actually negotiate higher commercial reimbursements so that they can get lower Medicare Advantage rates. Right, and you can see why, because the MA dollars are coming out of their own capitated pockets, whereas the commercial rates are being paid for by the ultimate purchasers, the plan sponsors. Also mentioned in this episode are Reid Strategic; Mark Cuban; Cora Opsahl; Bruce Rector, MD; Shawn Gremminger; Nina Lathia, RPh, MSc, PhD; Autumn Yongchu; Erik Davis; and Marty Makary, MD, MPH. Additional related episodes: EP380 with Mark Miller, PhD, on pharma communications. EP371 with Erik Davis and Autumn Yongchu on buy and bill versus pharmacy bagging. EP426 with Nina Lathia, RPh, MSc, PhD, on cost containment versus value-based drug purchasing. EP435 with Dan Mendelson from Morgan Health on how employers should consider pharma purchasing. EP365 with Scott Haas on PBM contracts and drug rebates. EP293 with Dea Belazi, PharmD, MPH, from AscellaHealth on co-pay cards, co-pay accumulators, and co-pay maximizers.   You can learn more by subscribing to Brian's newsletter and by following him on LinkedIn.   Brian Reid has nearly three decades of experience in healthcare journalism, public affairs, and public relations with a specialty in explaining the economics of the healthcare system. He is the founder of Reid Strategic, a communications consultancy, and a senior fellow at the Center for the Evaluation of Value and Risk in Health (CEVR) at Tufts Medical Center. At Reid Strategic, Brian counsels industry leaders on the best way to communicate on complex policy, access, pricing, and reimbursement issues in ways that critical audiences can understand. Brian's core belief is that we can't build a better healthcare system until everyone understands the system we have today. Reid Strategic offers communications strategy and execution around corporate, brand, and policy challenges, from prelaunch approaches to lifecycle management. Prior to founding Reid Strategic, Brian built and led Real Chemistry's Value+Access Communications practice, the largest such group dedicated to issues of value. Brian has written extensively for a range of audiences. At Reid Strategic, he publishes the daily Cost Curve newsletter; and his past experience includes coverage of the health science/policy beat for Bloomberg News, creation of patient education materials for the National Institutes of Health, and features in publications ranging from the Washington Post to Nature Biotechnology to Men's Health. He has a bachelor's degree in biology and political science from Emory University and a master's degree from the Columbia University School of Journalism.   08:29 Why is it important to understand the term “value” in respect to medicine? 10:07 Why is it important to consider all the players affected by the idea of this “value”? 11:06 Who are the ultimate purchasers in Pharma? 12:23 Findings of the Kaiser Employer Health Benefits Survey. 14:52 Why does it matter that we consider what value looks like to all players affected by Pharma? 16:46 EP300 with Bruce Rector, MD. 18:38 EP448 (Part 1) with Shawn Gremminger. 20:04 What does Pharma need to do to showcase their value when PBMs are often “locked in” at the moment? 23:11 Why Brian is celebrating companies that put their prices in their press releases. 32:31 Why does Pharma have an obligation to explain their value? 33:16 EP426 with Nina Lathia, RPh, MSc, PhD. 33:39 Why is it important for Pharma to keep an eye on hospital monopoly behavior? 35:55 EP370 with Erik Davis and Autumn Yongchu. 37:44 Why Pharma needs to capitalize on alignment.   You can learn more by subscribing to Brian's newsletter and by following him on LinkedIn.   Brian Reid, of Reid Strategic, discusses #pharma and #patientaffordability on our #healthcarepodcast. #healthcare #podcast #financialhealth #primarycare #patientoutcomes #healthcareinnovation   Recent past interviews: Click a guest's name for their latest RHV episode! Dr Beau Raymond, Brendan Keeler, Claire Brockbank, Cora Opsahl, Dan Nardi, Dr Spencer Dorn (EP451), Marilyn Bartlett, Dr Marty Makary, Shawn Gremminger (Part 2), Shawn Gremminger (Part 1), Elizabeth Mitchell (Summer Shorts 9)  

Conversations around GLP-1s in today's healthcare market are mixed. Some stakeholders are thrilled with their potential, while others are filled with questions and even anxiety about how these powerful and popular drugs will impact their business. Many in the industry have been asking for months: “What can GLP-1s do?” But maybe this is the wrong question. Leaders should be asking “What CAN'T GLP-1s do?” To answer that question, live from HLTH 2024, host Rachel (Rae) Wood invites Rob MacNaughton, CEO of lifestyle intervention and obesity management organization Calibrate, Rita Glaze-Rowe, President at life sciences research organization Real Chemistry, and Dr. Spencer Nadolsky, lipid and obesity specialist and founder to break down the cross-industry perspective on GLP-1s and how the healthcare leaders should be thinking about both the potential and limitations of these novel therapies. In a market that is buzzing around the novel medications, these experts suggest a new focus on comprehensive weight management programs. Links: Treating Obesity At Scale: Real-World Outcomes Using Medication And Intensive Lifestyle Intervention | Calibrate Real Chemistry - AI and Ideas Transforming Healthcare Ep. 222: It's not just GLP-1s; here's what comprehensive weight management looks like Ep. 159: Ozempic, Wegovy, and our questions on weight management drugs How 3 health systems provide comprehensive care for obesity 4 key elements of comprehensive obesity care (and how they look in practice) Join 165,000+ healthcare leaders and get the industry's most important news in your inbox—every day. What the 2024 elections mean for healthcare [Webinar, 10/24] How the 2024 elections could impact the healthcare industry A transcript of this episode as well as more information and resources can be found on www.advisory.com/RadioAdvisory.

Want to know what it takes to create award-winning work in healthcare advertising? Check out our final Cannesplaining Healthcare podcast episode, live from the 2024 Cannes Lions International Festival of Creativity, featuring our 21GRAMS, a part of Real Chemistry, creative leaders as they explore the intersection of creativity, marketing and healthcare. Discover how to make your health advertising stand out with insights from Real Chemistry Chief Creative Office & 21GRAMS Managing Founder Frank Mazzola, 21GRAMS Executive Creative Director Lauren Polina, Chief Creative Officer Tom Richards and Executive Creative Director Chris Charles.

Listen to Jack O'Brien of MM+M and Brandon Pletsch, president of scientific visualization at Real Chemistry, as they delve into the dynamic intersection of art, science and AI innovation in the field of scientific visualization. During the interview, they will discuss the role of scientific art in communicating complex scientific ideas to key stakeholders, how AI has been integrated into this process and what the future may hold for scientific artists.Check us out at: mmm-online.com   Follow us:  YouTube: @MMM-online TikTok: @MMMnews Instagram: @MMMnewsonline Twitter/X: @MMMnews LinkedIn: MM+M   To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.

Join us to explore current trends impacting healthcare public relations, focusing on how these are shaping health equity initiatives, as well as traditional and digital media landscapes. Featuring expert insights from Real Chemistry thought leaders, you'll hear share actionable advice and innovative strategies to more effectively reach audiences and achieve communications milestones.Follow us: @PRWeekUS Receive the latest industry news, insights, and special reports. Start Your Free 1-Month Trial Subscription To PRWeek

In the lead up to ASCO 2024, we hosted a discussion on the dynamic landscape of oncology today, looking through the lens of this year's meeting theme: the art and science of cancer care. Within two featured mini panels, we reviewed key trends and innovations and highlighted how intersections between art and science can help us change the face and future of the cancer experience. Touching on areas like advocacy, AI, screening and therapeutic advances, this can't miss conversation will help us envision a more effective and compassionate future in oncology.   The Art: The art of improving patient care. How industry collaborations, data-based messaging and campaigns and advocacy are helping to reach more patients earlier and more holistically. Ysabel Duron, Founder, President / Executive Director, The Latino Cancer Institute  Meredith Owen, Chief Revenue Officer, Analytics & Insights Group, Real Chemistry Shanthi Sivendran, MD, MSCR, MBA, Senior Vice President, Cancer Care Support, American Cancer Society    The Science: The latest therapeutics advancements in oncology. How technology is helping industry better engage providers and democratize science via visualization to help improve outcomes. HP Balaji, Senior Medical Director and TA Head, Bladder Cancer, Johnson & Johnson Innovative Medicine Brandon Pletsch, President, Scientific Visualization and Exhibit Experience, Real Chemistry

In this podcast, Larry Dobrow, executive, MM+M joins Nathan Minnich, SVP, Treace Medical and Real Chemistry's Brian Schwartz, chief growth officer, to discuss using creative minds, AI and analytics to inform fully integrated campaigns that are hyper-targeted, a little quirky and most importantly — attention-grabbing. Advertising elicits emotion. How do you strike the right balance between empathy and education when you have a short window to reach your audience? Hear from the experts. Check us out at: mmm-online.com   Follow us:  YouTube: @MMM-online TikTok: @MMMnews Instagram: @MMMnewsonline Twitter/X: @MMMnews LinkedIn: MM+M   To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.

In this episode of the Women Physicians Lead podcast, host Dr. Lisa welcomes Mary Stutts, CEO of the Healthcare Businesswomen's Association. Mary Stutts shares her experiences and insights on advancing women in healthcare leadership. She discusses the importance of diversity and inclusion, addressing the "broken rung," "paper ceiling," and "concrete ceiling" that hinder women's career progression. Stutts also highlights health equity, the impact of menopause on senior women leaders, and the potential of AI in healthcare. She urges women to advocate for themselves and stresses the need for companies to support women's advancement to ensure gender equality in the workplace. Introduction (00:00:00) Introducing Mary Stutts and her role as CEO of the Healthcare Business Women's Association. Mary Stutts' Leadership Journey (00:01:13) Details of Mary Stutts' extensive leadership experience in various organizations and her expertise in health equity. Influences on Pursuing Leadership (00:03:25) Mary Stutts discusses her career journey and the influential figures who supported her transition into healthcare leadership. Transitioning Between Roles (00:07:03) Mary Stutts shares her experiences of transitioning between different roles in the healthcare industry and the importance of proactive decision-making. Health Equity and Corporate Social Responsibility (00:18:35) Discussion about the importance of incorporating health equity into diversity and inclusion programs for better employee engagement and success. Strategic Leadership Experiences (00:22:46) Importance of gaining specific leadership experiences, including managing a P&L, mentoring, and job rotations, for women to become strategic leaders. Advocacy for Women CEOs (00:23:57) Mary's proactive approach in advocating for roles, including creating a health equity practice at Real Chemistry and her involvement with the Healthcare Business Women's Association (HBA). CEO Role at HBA (00:28:24) Mary's approach to her role as CEO at HBA, including conducting a listening tour, identifying priorities, and planning a strategy stretch for the organization. Supporting Women in Leadership (00:36:46) Mary's thoughts on how organizations can rally around women to support their leadership development and increase the pipeline of women serving in leadership roles. Recruiting, Developing, and Retaining Women in the Workplace (00:36:46) Importance of companies being intentional about recruiting, developing, retaining, and promoting women in decision-making roles. Hiring More Women of Color and Breaking the Concrete Ceiling (00:39:06) Urgency to hire more women of color, particularly black, Latino, and Asian women, and the difficulty women face in breaking through to the first director-level job. Health and Wellness in C-Suite Roles (00:41:39) Discussion about the physical and mental health challenges faced by senior-level women and the importance of self-care. Empowerment and Networking for Women (00:47:25) Importance of remaining diligent, aware, and fostering strong relationships and networks to empower women personally and professionally. Let's Connect! If you're navigating the choppy waters of a career transition or seeking support as you step into a leadership role, I'm here for you. Schedule a career transition discovery call with me here, and let's chart a course to your dream destination.

Jim Weiss has evolved Real Chemistry from a one-person consultancy into an international leader in health innovation. Currently, he serves as Chairman and Founder and as Executive Advisor to New Mountain Capital, Real Chemistry's investment partner. Jim is a healthcare, biopharma, medical tech entrepreneur, business leader, and digital health pioneer. He's been named a Top 50 Health Influencer and Innovator of the Year. Last year, he received the Trailblazer Lifetime Achievement Award.  His affable curiosity began in our hometown of Honesdale, Pennsylvania, and was furthered at his alma mater, Syracuse University, where he was inducted into the Newhouse School's 50 Forward as one of its most accomplished graduates of the last 50 years. Jim and his wife Audra also founded the Weiss Center for Social Commerce at S.I. Newhouse School of Public Communications. In this episode, Jim talks with Todd Stephens about taking the leap from big pharma to launching a start-up. He recounts his early days becoming the leader that, perhaps, no one saw coming. He also touches on the next phase of his career. Through it all, Jim says his commitment to family and giving back kept him grounded. Still, he dispels the myth of work-life balance. He believes the pursuit of “downtime” and "work time" will usually merge. When he's not working, he loves to watch his Northern California teams and listen to The Grateful Dead or see Dead and Co. live! Jim resides with his wife and two children in the Bay Area.  See omnystudio.com/listener for privacy information.

In this episode, Suzanne Jacobs, Group President of Medical at Real Chemistry, and Trina Stonner, President of Avant Healthcare, discuss Real Chemistry's newly announced acquisition of Avant Healthcare, how the two companies came together and have similar ethos of supporting physicians in advancing patient care, and how the future of medical communications will involve a combination of data, creativity, AI, and human expertise. 

In this podcast, we'll bring together three of the PRWeek Health Influencer 30 winners to discuss the importance of healthcare communications and outline key themes for healthcare communicators leading into 2024.Follow us: @PRWeekUS Receive the latest industry news, insights, and special reports. Start Your Free 1-Month Trial Subscription To PRWeek

It's time to talk about cancer prevention and early detection. Join us as we explore the importance of early detection and prevention in the fight against cancer with Dr. Karen Knudsen, CEO of the American Cancer Society, and Jim Weiss, Founder and Chairman at Real Chemistry. Tune in to learn about the role of the American Cancer Society in research, advocacy and patient support, the importance of genetic testing in understanding cancer risk and the future of cancer testing and the role of AI.

Listen to our latest podcast with Peter Lee, Corporate Vice President of Research and Incubations at Microsoft, and Brandon Pletsch, Practice Leader of Scientific Visualization at Real Chemistry, to learn about the applications and implications of generative AI, specifically GPT-4, in healthcare and other fields. They explore public perceptions of AI, its potential benefits and risks, the importance of ethical considerations and regulatory guidelines, and the concept of equitable access to AI in healthcare. Check out the episode to gain insight into how AI can revolutionize fields outside of human language and thought.

Learn more about the inspiring journey of Jason Gardner, Head of Medical at Real Chemistry, and his views on AI and DE&I in healthcare. From his father's struggle with multiple sclerosis to his strategic approach to medical communications, Jason shares his unique perspectives on how diverse thinking and experiences can bring value to the healthcare industry.

In this episode, Javeria Shahab, President of Medical Education at 21GRAMS, a part of Real Chemistry, discusses the challenges and changes in the medical education industry, building effective teams and the importance of empathy in healthcare communications. Get an insider's look into the industry and hear Javeria's advice for those looking to break into the field.

In this episode, Dr. Sue Desmond-Hellmann, Member of President Biden's Council of Advisors on Science and Technology and former CEO of the Bill & Melinda Gates Foundation, Mike Huckman, Global Practice Leader of Executive Communications at Real Chemistry, and Jim Weiss, Founder and Chairman at Real Chemistry, discuss the importance of vaccination, the evolution of cancer treatments and the challenges of clinical trials. They also highlight the need for diverse representation in clinical trials, the implications of the Inflation Reduction Act on the pharmaceutical industry and the influence of science in public health and policymaking.

The Dallas Mavericks have STILL only played 2 games but do Luka Doncic & Christian Wood have real chemistry? Will Facundo Campazzo play for the Mavs against the New Orleans Pelicans?Nick Angstadt (@NickVanExit) and Isaac Harris (@IsaacLHarris) discuss what they've learned about the Mavs so far this season, what to expect from Facu Campazzo who is now cleared to play, and more. What's one thing the Mavs will be able to sustain from this start? Then they grade your OVERREACTIONS from yesterday's show. Who overreacted and who underreacted?Subscribe to our Youtube Channel: Locked On MavericksFollow/Subscribe Anywhere: linktr.ee/LockedOnMavsFollow Locked On NBA: linktr.ee/LockedOnNBA Support Us By Supporting Our Sponsors! | Offers from our sponsors: lockedonpodcasts.com/offersBetOnline — Today's Episode is brought to you by BetOnline. BetOnline has you covered this season with more props, odds and lines than ever before. BetOnline – Where The Game Starts!LinkedIn — Today's episode is brought to you by LinkedIn. LinkedIn Jobs helps you find the qualified candidates you want to talk to, faster. Post your job for free at LinkedIn Dot Com slash LOCKEDONNBAPrizePicks — Today's episode is brought to you by PrizePicks. First time users can receive a 100% instant deposit match up to $100 with promo code LOCKEDON. That's PrizePicks.com – promo code; LOCKEDON Learn more about your ad choices. Visit podcastchoices.com/adchoices

The Dallas Mavericks have STILL only played 2 games but do Luka Doncic & Christian Wood have real chemistry? Will Facundo Campazzo play for the Mavs against the New Orleans Pelicans? Nick Angstadt (@NickVanExit) and Isaac Harris (@IsaacLHarris) discuss what they've learned about the Mavs so far this season, what to expect from Facu Campazzo who is now cleared to play, and more. What's one thing the Mavs will be able to sustain from this start? Then they grade your OVERREACTIONS from yesterday's show. Who overreacted and who underreacted? Subscribe to our Youtube Channel: Locked On Mavericks Follow/Subscribe Anywhere: linktr.ee/LockedOnMavs Follow Locked On NBA: linktr.ee/LockedOnNBA   Support Us By Supporting Our Sponsors! | Offers from our sponsors: lockedonpodcasts.com/offers BetOnline — Today's Episode is brought to you by BetOnline. BetOnline has you covered this season with more props, odds and lines than ever before. BetOnline – Where The Game Starts! LinkedIn — Today's episode is brought to you by LinkedIn. LinkedIn Jobs helps you find the qualified candidates you want to talk to, faster. Post your job for free at LinkedIn Dot Com slash LOCKEDONNBA PrizePicks — Today's episode is brought to you by PrizePicks. First time users can receive a 100% instant deposit match up to $100 with promo code LOCKEDON. That's PrizePicks.com – promo code; LOCKEDON Learn more about your ad choices. Visit podcastchoices.com/adchoices